MCI-154, a Ca2+ sensitizer, decreases the oxygen cost of contractility in isolated canine hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 4 42-4, 1997, Pages

  Onishi, Katsuya ^a   Sekioka, Kiyotsugu ^a   Ishisu, Ryoichi ^a   Abe, Yuji ^a,b   Tanaka, Hideyuki ^a   Nakamura, Mashio ^a   Ueda, Yuji ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Dog; Myocardial energetics; Pressure volume area

Indexed keywords

4,5 DIHYDRO 6 [4 (4 PYRIDYLAMINO)PHENYL] 3(2H) PYRIDAZINONE; CALCIUM; POTASSIUM CHLORIDE; PYRIDAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG EFFECT; ENERGY CONSERVATION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEART VENTRICLE PRESSURE; HEART VENTRICLE VOLUME; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; BLOOD VOLUME; ENERGY METABOLISM; HEART ARREST; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; IN VITRO STUDY; METABOLISM; OXYGEN CONSUMPTION;

ANIMALS; BLOOD PRESSURE; BLOOD VOLUME; CALCIUM; DOGS; ENERGY METABOLISM; HEART ARREST, INDUCED; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXYGEN CONSUMPTION; POTASSIUM CHLORIDE; PYRIDAZINES; VENTRICULAR FUNCTION, LEFT;

EID: 0030703531     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.4.h1688     Document Type: Article

References (21)

1. Abe, Y., R. Ishisu, K. Onishi, K. Sekioka, A. Narimatsu, and T. Nakano. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154. J. Pharmacol. Exp. Ther. 276: 433-439, 1996.
2. Abe, Y., Y. Kitada, and A. Narimatsu. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs. J. Pharmacol. Exp. Ther. 265: 819-825, 1993.
3. Armitage, P., and G. Berry. Statistical Methods in Medical Research (2nd ed.). Oxford, UK: Blackwell Scientific, 1987.
4. Bethke, T., W. Meyer, W. Schmitz, H. Scholz, H. Wenzlaff, B. I. Armah, R. Bruckner, and A. Raap. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium. J. Cardiovasc. Pharmacol. 21: 847-855, 1993.
5. Bohm, M., I. Morano, B. Pieske, J. C. Ruegg, M. Wankerl, R. Zimmermann, and E. Erdmann. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to inotropic effect of pimobendan in the failing human myocardium. Circ. Res. 68: 689-701, 1991.
6. Chandler, B. M., E. H. Sonnenblick, and P. E. Pool. Mechano-chemistry of cardiac muscle III. Effects of norepinephrine on the utilization of high-energy phosphates. Circ. Res. 22: 729-735, 1968.
7. De Tombe, P. P., D. Burkhoff, and W. C. Hunter. Effects of calcium and EMD-53998 on oxygen consumption in isolated canine hearts. Circulation 86: 1945-1954, 1992.
8. Gibbs, C. L. Cardiac energetics. Physiol. Rev. 58: 174-254, 1978.
9. Hasselbach, W., and H. Oetliker. Energetics and electrogenicity of the sarcoplasmic reticulum calcium pump. Annu. Rev. Physiol. 45: 325-339, 1983.
10. Hata, K., Y. Goto, S. Futaki, Y. Ohgoshi, H. Yaku, O. Kawaguchi, T. Takasago, A. Saeki, T. W. Taylor, T. Nishioka, and H. Suga. Mechanoenergetic effects of pimobendan in canine left ventricles. Comparison with dobutamine. Circulation 86: 1291-1301, 1992.
11. Hata, K., Y. Goto, O. Kawaguchi, T. Takasago, A. Saeki, T. Nishioka, and H. Suga. Hypercapnic acidosis increases oxygen cost of contractility in the dog left ventricle. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H730-H740, 1994.
12. Holubarsch, C., G. Hasenfuss, H. Just, E. Blanchard, L. A. Mulieri, and N. R. Alpert. Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles. J. Cardiovasc. Pharmacol. 14, Suppl. 2: S13-S17, 1989.
13. Ishisu, R., Y. Abe, K. Onishi, K. Sekioka, and T. Nakano. Differential effects of EMD-53998 on calcium-pressure relationship in normal and ischemic guinea pig heart. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H311-H319, 1996.
14. Kass, D. A., and W. L. Maughan. From "Emax" to pressure-volume relations: a broader view. Circulation 77: 1203-1212, 1988.
15. 2+ binding by MCI-154, a novel cardiotonic agent. J. Pharmacol. Exp. Ther. 250: 272-277, 1989.
16. 2+ in skinned cardiac muscles. Jpn. J. Pharmacol. 50: 411-419, 1989.
17. 2+ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles. J. Pharmacol. Exp. Ther. 243: 633-638, 1987.
18. Kitada, Y., A. Narimatsu, R. Suzuki, M. Endoh, and N. Taira. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? J. Pharmacol. Exp. Ther. 243: 639-645, 1987.
19. Lee, J. A., J. C. Ruegg, and D. G. Allen. Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle. Clin. Sci. (Lond.) 76: 609-618, 1989.
20. 2+-regulated interactions between troponin subunits from bovine heart. J. Pharmacol. Exp. Ther. 270: 831-839, 1994.
21. Lues, I., N. Beier, R. Jonas, M. Klockow, and G. Haeusler. The two mechanisms of action of racemic cardiotonic EMD-53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. J. Cardiovasc. Pharmacol. 21: 883-892, 1993.